Designing clinical trials for continuous combined therapy

Zichella L . Clinical management of the menopausal woman. Int J Fertil Menopausal Stud 1993; 38: 15-22.

Oldenhave A , Netelenbos C . Pathogenesis of climacteric complaints: Ready for the change? Lancet 1994; 343: 649-53.

Grodstein F , Stampfer MJ , Manson JE Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.

Cauley JA , Seeley DG , Browner WS Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures. Arch Intern Med 1997; 157: 2181-7.

Henderson VW , Watt L , Buckwalter JG . Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996; 21: 421-30.

Christiansen C , Riis BJ . Hormonal replacement therapy and the skeletal system. Maturitas 1990; 12: 247-57.

Ziel HK . Estrogen's role in endometrial cancer. Obstet Gynecol 1982; 60: 509-15.

Pickar JH . Endometrial risks with hormone replacement therapy. In: Studd JWW , ed. The Management of the Menopause: Annual Review, 1998. Parthenon Pub Group, 1998: 111-20.

Mattsson L-Å , Samsioe G . Estrogen - progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen. Acta Obstet Gynecol Scand 1985; 131: 53-8.

Whitehead MI , Townsend PT , Pryse-Davies J , Ryder TA , King RJ . Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981; 305: 1599-605.

Persson I , Adami H-O , Bergkvist L Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study. BMJ 1989; 298: 147-51.

Mattsson LÅ . Continuous combined HRT: A possible way to avoid uterine bleeding. The modern management of the menopause 1993; 49: 453-62.

Stadberg E , Mattsson LA , Milsom I . Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study. Maturitas 1997; 27: 109-16.

Hahn RG . Compliance considerations with estrogen replacement: Withdrawal bleeding and other factors. Am J Obstet Gynecol 1989; 161: 1854-8.

Ryan PJ , Harrison R , Blake GM , Fogelman I . Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992; 99: 325-8.

Staland B . Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 1981; 3: 146-56.

Sporrong T , Hellgren M , Samsioe G , Mattsson LA . Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988; 95: 1042-8.

Wiederpass E , Adami HO , Baron JA Risk of endometrial Cancer following estrogen replacement with and without progestins. J Nat Cancer Inst 1999; 91: 1131-7.

Udoff L , Langenberg P , Adashi EY . Combined continuous hormone replacement therapy: A critical review. Obstet Gynecol 1995; 86: 306-16.

Kupperman HS , Blatt MHG , Wiesbader H , Filler W . Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Endocinol Metab 1953; 13: 688-703.

Wiklund I , Holst J , Karlberg J A new methodology for evaluating quality folife in postmenopausal women during transdermal estrgoen replacement therapy. Maturitas 1992; 14: 211-24.

Greene JG . A factor analytic study of climateric. J Psychosom Res 1976; 20: 425-30.

Aitken R . Measurement of feelings using visual analogue scales. Proc R Soc Med 1969; 62: 989-93.

Rubinow DR , Roy-Byrne P , Hoban MC Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984; 141: 684-6.

Matsson LÅ , Cullberg G , Samsioe G . Evaluation of a continuous estrogen-progestogen regimen for climacteric complaints, Maturitas 1982; 4: 95-102.

Baerug U , Winge T , Nordland G Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric 1998; 1: 219-28.

Stadberg E , Mattsson LÅ , Uvebrant M . 17-beta estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas 1996; 23: 31-9.

Bruhat M , Rudolf K , Vaheri R , 1999 New concept in continuous combined hormone replacement therapy. A comparison with conventional treatment. Climacteric 1999; 2(Suppl 1): 98.

Archer DF , Pickar JH , Bottiglioni . Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 1994; 83: 686-92.

Archer DF , Dorin MH , Heine W Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Obstet Gynecol 1999; 94; 323-9.

Archer DF , McIntyre-Seltman K , Wilborn WW Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991; 165: 317-22.

Korhonen MO , Symons JP , Hyde BM Histologic classification and pathologic findings for endometrial biopsy Specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy Am J Obstet Gynecol 1997; 176: 377-80.

Grimes DA . Diagnostic dilation and curettage: A reappraisal. Am J Obstet Gynecol 1982; 142: 1-6.

Alberico S , Elia A , Dal Corso L , Mandruzzato GP , Di Bonito L , Patriarca S . Diagnostic validity of the Vabra curettage. J Gynaecol Oncol 1986; 7: 135-8.

Eddowes HA , Read MD , Codling BW . Pipelle: A more acceptable technique for outpatient endometrial biopsy. Br J Obstet Gynaecol 1990; 97: 961-2.

Sporrong T , Hellgren M , Samsioe G , Mattson LÅ . Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988; 95: 1042-8.

Clisham PR , de Ziegler D , Lozano K , Judd HL . Comparison of Continuous Versus Sequential Estrogen and Progestin Therapy in Postmenopausal Women. Obstet Gynaecol 1991; 77: 241-6.

Lindgren R , Risberg B , Hammar M , Berg G , Pryse-Davies J . Endometrial effects of transdermal estradiol/norethisterone acetate. Maturitas 1992; 15: 71-8.

AinMelk Y . Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: A randomized trial. Fertil Steril 1996; 66: 962-8.

Hillard TC , Siddle NC , Fraser DI , Pryse-Davies J . Continuous combined equine estrogen-progestogen therapy: Effects of medroxyprogesterone acetae and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis. Am J Obstet Gynecol 1992; 167: 1-7.

Whitehead MI , Hillard TC , Crook D . The role and use of progestogens. Obstet Gynecol 1990; 75(Suppl): S59-S76.

Farrell T , Jones N , Owen P , Baird A . The significance of an insufficient Pipelle sample in the investigation of postmenopausal bleeding. Acta Obstet Gynecol Scand 1999; 78: 810-2.

Goldstein SR , Nachtigall M , Snyder JR , Nachtigall L . Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J of Obstet Gynecol 1990; 163: 119-23.

Nasri MN , Shepherd JH , Setchell ME , Lowe DG , and Chard T . The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynecology 1991; 98: 470-5.

Varner RE , Sparks JM , Cameron CD , Roberts LL , and Soong S-J . Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 1991; 78: 195-9.

Lindgren R , Mattsson LA , Andersson K Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol 1999; 106: 421-6.

Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646-50.

World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843. Geneva: WHO, 1994

Consensus development statement? Who are candidates for prevention and treatment of osteoporosis. Osteoporosis Int 1997; 7: 1-6.

Hannon R , Eastell R . Bone metabolism and osteoporosis. J Br Meno Soc 1998; 4: 103-06.